A collagen–chitosan hydrogel for endothelial differentiation and angiogenesis.

Cell therapy for the treatment of cardiovascular disease has been hindered by low cell engraftment, poor survival, and inadequate phenotype and function. In this study, we added chitosan to a previously developed injectable collagen matrix, with the aim of improving its properties for cell therapy and neovascularization. Different ratios of collagen and chitosan were mixed and chemically crosslinked to produce hydrogels. Swell and degradation assays showed that chitosan improved the stability of the collagen hydrogel. In culture, endothelial cells formed significantly more vascular-like structures on collagen–chitosan than collagen-only matrix. While the differentiation of circulating progenitor cells to CD31+ cells was equal on all matrices, vascular endothelial-cadherin expression was increased on the collagen–chitosan matrix, suggesting greater maturation of the endothelial cells. In addition, the collagen–chitosan matrix supported a significantly greater number of CD133+ progenitor cells than the collagen-only matrix. In vivo, subcutaneously implanted collagen–chitosan matrices stimulated greater vascular growth and recruited more von Willebrand factor (vWF+) and CXCR4+ endothelial/angiogenic cells than the collagen-only matrix. These results indicate that the addition of chitosan can improve the physical properties of collagen matrices, and enhance their ability to support endothelial cells and angiogenesis for use in cardiovascular tissue engineering applications.

[1]  A A Poot,et al.  Binding and release of basic fibroblast growth factor from heparinized collagen matrices. , 2001, Biomaterials.

[2]  Rejean Munger,et al.  A simple, cross-linked collagen tissue substitute for corneal implantation. , 2006, Investigative ophthalmology & visual science.

[3]  Xudong Cao,et al.  An acellular matrix‐bound ligand enhances the mobilization, recruitment and therapeutic effects of circulating progenitor cells in a hindlimb ischemia model , 2009, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[4]  A. Mikos,et al.  Crosslinking characteristics of and cell adhesion to an injectable poly(propylene fumarate-co-ethylene glycol) hydrogel using a water-soluble crosslinking system. , 2003, Tissue engineering.

[5]  Fengfu Li,et al.  PEG-stabilized carbodiimide crosslinked collagen-chitosan hydrogels for corneal tissue engineering. , 2008, Biomaterials.

[6]  M. Simons,et al.  Arteriogenesis: lessons learned from clinical trials. , 2003, Endothelium : journal of endothelial cell research.

[7]  O. Damour,et al.  Chitosan-chondroitin sulfate and chitosan-hyaluronate polyelectrolyte complexes: biological properties. , 1998, Biomaterials.

[8]  Yan Zhang,et al.  Collagen-Based Matrices Improve the Delivery of Transplanted Circulating Progenitor Cells: Development and Demonstration by Ex Vivo Radionuclide Cell Labeling and In Vivo Tracking With Positron-Emission Tomography , 2008, Circulation. Cardiovascular imaging.

[9]  W. Franz,et al.  Myocardial tissue engineering. , 2002, Ernst Schering Research Foundation workshop.

[10]  Theo Kofidis,et al.  Novel Injectable Bioartificial Tissue Facilitates Targeted, Less Invasive, Large-Scale Tissue Restoration on the Beating Heart After Myocardial Injury , 2005, Circulation.

[11]  A. Zeiher,et al.  CXCR4 Expression Determines Functional Activity of Bone Marrow–Derived Mononuclear Cells for Therapeutic Neovascularization in Acute Ischemia , 2009, Arteriosclerosis, thrombosis, and vascular biology.

[12]  R. Nerem,et al.  Embryonic Stem Cell-Derived Endothelial Cells May Lack Complete Functional Maturation in vitro , 2006, Journal of Vascular Research.

[13]  Joel Price,et al.  Tissue-Engineered Injectable Collagen-Based Matrices for Improved Cell Delivery and Vascularization of Ischemic Tissue Using CD133+ Progenitors Expanded From the Peripheral Blood , 2006, Circulation.

[14]  P. Quax,et al.  Expression of Vascular Endothelial Growth Factor, Stromal Cell-Derived Factor-1, and CXCR4 in Human Limb Muscle With Acute and Chronic Ischemia , 2007, Arteriosclerosis, thrombosis, and vascular biology.

[15]  H. Lee,et al.  Chitosan gel as an in situ-forming scaffold for rat bone marrow mesenchymal stem cells in vivo. , 2008, Tissue engineering. Part A.

[16]  Rafael Beyar,et al.  Transplantation of human embryonic stem cell-derived cardiomyocytes improves myocardial performance in infarcted rat hearts. , 2007, Journal of the American College of Cardiology.

[17]  M. Ruel,et al.  Effects of off-pump versus on-pump coronary artery bypass grafting on function and viability of circulating endothelial progenitor cells. , 2005, The Journal of thoracic and cardiovascular surgery.

[18]  H. Saimoto,et al.  Biological activities of carbohydrate-branched chitosan derivatives. , 2001, Biomacromolecules.

[19]  Lil Pabon,et al.  Regeneration gaps: observations on stem cells and cardiac repair. , 2006, Journal of the American College of Cardiology.

[20]  B. Wilson,et al.  Tracking cardiac engraftment and distribution of implanted bone marrow cells: Comparing intra-aortic, intravenous, and intramyocardial delivery. , 2009, The Journal of thoracic and cardiovascular surgery.

[21]  I. Zvibel,et al.  Anoikis: Roadblock to Cell Transplantation? , 2002, Cell transplantation.

[22]  Masanori Fujita,et al.  Vascularization in vivo caused by the controlled release of fibroblast growth factor-2 from an injectable chitosan/non-anticoagulant heparin hydrogel. , 2004, Biomaterials.

[23]  H. Lee,et al.  Chitosan Gel as an In Situ–Forming Scaffold for Rat Bone Marrow Mesenchymal Stem Cells In Vivo , 2008 .

[24]  M. Gnecchi,et al.  Paracrine Mechanisms in Adult Stem Cell Signaling and Therapy , 2008, Circulation research.

[25]  Randall J Lee,et al.  Fibrin glue alone and skeletal myoblasts in a fibrin scaffold preserve cardiac function after myocardial infarction. , 2004, Tissue engineering.

[26]  E. Fuchs,et al.  Socializing with the Neighbors Stem Cells and Their Niche , 2004, Cell.

[27]  Johan Hoebeke,et al.  Differential binding of platelet-derived growth factor isoforms to glycosaminoglycans , 2003, Histochemistry and Cell Biology.

[28]  Tong Hao,et al.  Functional improvement of infarcted heart by co-injection of embryonic stem cells with temperature-responsive chitosan hydrogel. , 2009, Tissue engineering. Part A.

[29]  D. Ornitz,et al.  FGFs, heparan sulfate and FGFRs: complex interactions essential for development. , 2000, BioEssays : news and reviews in molecular, cellular and developmental biology.

[30]  P. Carmeliet,et al.  Targeted Deficiency or Cytosolic Truncation of the VE-cadherin Gene in Mice Impairs VEGF-Mediated Endothelial Survival and Angiogenesis , 1999, Cell.

[31]  Y. Yoon,et al.  Role of host tissues for sustained humoral effects after endothelial progenitor cell transplantation into the ischemic heart , 2007, The Journal of experimental medicine.

[32]  M. Cheitlin.  Adult Bone Marrow–Derived Cells for Cardiac Repair: A Systematic Review and Meta-analysis , 2008 .

[33]  R. Béliveau,et al.  Human vascular endothelial cells with extended life spans: In vitro cell response, protein expression, and angiogenesis , 2004, Angiogenesis.

[34]  Lila R Collins,et al.  Cardiomyocytes derived from human embryonic stem cells in pro-survival factors enhance function of infarcted rat hearts , 2007, Nature Biotechnology.

[35]  J. Gluckman,et al.  Glycan and glycosaminoglycan binding properties of stromal cell-derived factor (SDF)-1alpha. , 2000, Glycobiology.

[36]  M D McKee,et al.  Tissue engineering of cartilage using an injectable and adhesive chitosan-based cell-delivery vehicle. , 2005, Osteoarthritis and cartilage.

[37]  Stephen J Riederer,et al.  Dynamic Tracking During Intracoronary Injection of 18F-FDG-Labeled Progenitor Cell Therapy for Acute Myocardial Infarction , 2007, Journal of Nuclear Medicine.